Cognitive ageing
Human evidence and active trials are visible in this field
102 human-evidence records · 13 active trials · 555 visible funding records · 6,740 universities
Australian Patent Application
Omega-3 fatty acid and vitamin D levels to identify and attenuate cognitive aging in individuals
Source-linked patent metadata for Omega-3 fatty acid and vitamin D levels to identify and attenuate cognitive aging in individuals, including priority, record stage and longevity-topic connections.
Australian application snapshot
Patent application record
This privacy-minimal view describes one official Australian patent application record. It is not presented as a complete worldwide patent family.
- Application number
- AU2017408873
- Earliest priority
- April 11, 2017
- Application date
- August 13, 2019
- Source record
- 1
- Patent offices
- 1
Patent-to-Evidence Translation Map
What is happening in the same scientific field?
These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.
Omega-3 fatty acids
Human evidence and registered trials are visible in this field
65 human-evidence records · 0 active trials · 1 visible funding records · 6,176 universities
Vitamin D and ageing
Human evidence and active trials are visible in this field
242 human-evidence records · 3 active trials · 7 visible funding records · 6,264 universities
Why names are absent
This feed intentionally excludes party names and contact details to minimise personal data. Open the official record when a name is consequential.
Topics connected by metadata
Cognitive ageing82% metadata match
Omega-3 fatty acids82% metadata match
Vitamin D and ageing82% metadata match
How the patent office classifies this invention
A61K31/14 · A61K31/202 · A61K31/4415 · A61K31/51 · A61K31/592 · A61K31/593 · A61P25/28
Verify in the original patent source →